Roundtable Discussion: Discussing Regulatory Strategies indications for Dose Optimisation & Expansion with Cytokine-based Drugs

Time: 10:00 am
day: Conference Day One

Details:

Overview on the history and evolution of Project Optimus and its application to understand how to manoeuvre in the regulatory environment when developing cytokines with an FDA perspective when approaching FDA optimisation Discussing the pros and cos of Project Optimus to advance the regulatory development plan

Interactive discussion with the attendees about their experiences in the regulatory landscape to successfully navigate regulatory issues 10.45 Morning

Speakers: